SecBot SecBot
6-K ·Filed Apr 15, 2026

BRSYF

Brainsway Ltd.
BULLISH
Impact 7/10
Horizonmonths Processed7mo ago SEC0001171843-26-002457
Notable filing: 6-K
Actionable Insight ▲ Bullish

Traders should view this as a positive catalyst for Brainsway's commercial growth, as broader payer support for NP-administered TMS could accelerate adoption in underserved areas. Monitor future quarterly revenue trends and commentary on treatment volume for validation of this expansion.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$13.55
T+0 close · Apr 15, 2026 · via day close
Latest settled
+11.66%
T+60 · $15.13
Vs SPY
+3.52%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 15 $13.55entry
  2. T+1 · 7mo ago 0.00%α −0.25% · $13.55
  3. T+5 · 7mo ago 0.00%α −1.64% · $13.55
  4. T+20 · 6mo ago +24.28%α +18.24% · $16.84
  5. T+60 · 4mo ago +11.66%α +3.52% · $15.13

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Brainsway highlighted expanding U.S. payer coverage allowing nurse practitioners to administer its Deep TMS therapy, including a key policy update from Optum/United Behavioral Health covering 34.8 million lives. This shift is expected to broaden access to treatment by addressing clinician shortages, potentially increasing utilization of Brainsway's devices.

Key Facts

  • Optum/United Behavioral Health updated its TMS clinical policy in late 2025 to allow psychiatric mental health nurse practitioners (PMHNPs) to order, supervise, and administer TMS therapy in states with full practice authority.
  • The Optum policy change applies to commercial plans covering approximately 34.8 million lives.
  • Other major payers, including Medicare Administrative Contractors (First Coast, National Government Services, Novitas), the U.S. Department of Veterans Affairs, and TRICARE West, have also adopted similar policies.
  • Previously, TMS administration under Optum's policy was limited to psychiatrists.
  • Brainsway states this trend removes structural barriers and expands access to its FDA-cleared Deep TMS treatments for depression, OCD, and smoking addiction.

Financial Impact

Potential revenue upside from increased treatment adoption due to expanded provider pool; Optum's coverage alone represents a significant portion of the U.S. commercial insurance market.

revenueutilizationmarket penetration

Risk Factors

  • Impact may be gradual as clinics adapt to new provider models.
  • Reimbursement rates and prior authorization requirements still vary by payer and could limit uptake.
  • Forward-looking statements are subject to regulatory, operational, and market risks as detailed in the filing.

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-002457
Document: f6k_041426.htm0001171843-26-002457
Document: 0001171843-26-002457-index-headers.html0001171843-26-002457
Document: 0001171843-26-002457-index.html0001171843-26-002457
Document: 0001171843-26-002457.txt0001171843-26-002457

Track record

5 reports on BRSYF

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +24.28% at T+20 after the Apr 20, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Jun 9, 202622w ago 6-K Bullish 7/10 Entry $16.84 to $15.13 Now $10.62 −36.94% ▼ −10.15% −14.24% vs SPY
  2. May 18, 202626w ago 6-K Neutral 4/10 Entry $16.84 to $15.13 Now $10.62 −36.94% ▼ −10.15% −15.01% vs SPY
  3. May 13, 202626w ago 6-K Bullish 8/10 Entry $16.84 to $15.13 Now $10.62 −36.94% ▼ −10.15% −14.59% vs SPY
  4. Apr 20, 202630w ago 20-F Bullish 7/10 Entry $13.55 to $15.13 Now $10.62 −21.62% ▲ +11.66% +4.76% vs SPY
  5. Apr 15, 202630w ago 6-K Bullish 7/10 Viewing Entry $13.55 to $15.13 Now $10.62 −21.62% ▲ +11.66% +3.52% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Wed (10h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026